Subscribe to RSS - ResMed

ResMed

Travel CPAP ready for ‘next wave’

 - 
04/06/2018

YARMOUTH, Maine – Providers expect to see sales of travel CPAPs increase as the devices become more visible in the public domain.

In brief: AAH ‘embraces’ e-prescribing, Medicare Advantage gets 3.4% increase

 - 
04/06/2018

WASHINGTON – AAHomecare’s Executive Committee will examine e-prescribing platforms to recommend the best solution for its provider members.

ResMed names Ghoshal CTO

 - 
04/03/2018

SAN DIEGO – ResMed didn’t have to look far to find its first chief technology officer. The company announced April 2 that it had named Bobby Ghoshal as CTO.

ResMed highlights ‘positive’ tax changes

 - 
02/27/2018

SAN DIEGO – Tax reform recently passed by Congress has “liberated our global cash assets to be able to be invested without artificial constraints,” ResMed CEO Mick Farrell said during a Jan. 22 conference call.

ATS, ResMed award $100,000 grant for vent research

 - 
02/13/2018

SAN DIEGO – Dr. Jeremy Orr of the University of California, San Diego, has been awarded the new ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation in COPD. Dr.

Increased awareness buoys ResMed’s growth

 - 
01/26/2018

SAN DIEGO – ResMed posted double-digit growth across the device and mask product categories for the second quarter of fiscal year 2018.

In brief: VA, HHS partner on fraud prevention; Beacon transitions HME biz to Alick’s

 - 
01/26/2018

WASHINGTON – The U.S. Department of Veterans Affairs, the Department of Health and Human Services and CMS are partnering to strengthen fraud prevention efforts.

Study: ASV better for central apnea patients

 - 
01/24/2018

SAN DIEGO – Patients with central sleep apnea who switch from positive airway pressure to adaptive servo ventilation therapy may be more adherent to therapy, according to a ResMed-funded study published in the Journal of Clinical Sleep Medicine.

ResMed boasts double-digit growth, with ‘more runway ahead’

 - 
01/23/2018

SAN DIEGO – ResMed on Jan. 22 reported revenues of $601.3 million for the second quarter of fiscal year 2018, a 13% increased compared to the same quarter last year. Revenues in the U.S., Canada and Latin America, excluding Brightree, were $329.2 million, a 12% increase.

ResMed debuts Mobi

 - 
01/09/2018

SAN FRANCISCO – ResMed has formally introduced its first portable oxygen concentrator to the market. The company says Mobi will be available to U.S. patients through their HME providers later this quarter, and it is pursuing clearance to sell in other countries in 2018.

Pages